| __timestamp | Sarepta Therapeutics, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 49315000 | 17992000000 |
| Thursday, January 1, 2015 | 75043000 | 22400000000 |
| Friday, January 1, 2016 | 83749000 | 23910000000 |
| Sunday, January 1, 2017 | 122682000 | 23813000000 |
| Monday, January 1, 2018 | 207761000 | 24694000000 |
| Tuesday, January 1, 2019 | 284812000 | 23557000000 |
| Wednesday, January 1, 2020 | 317875000 | 25436000000 |
| Friday, January 1, 2021 | 282660000 | 24586000000 |
| Saturday, January 1, 2022 | 451421000 | 27295000000 |
| Sunday, January 1, 2023 | 481871000 | 34205000000 |
| Monday, January 1, 2024 | 28113000000 |
Infusing magic into the data realm
In the ever-evolving landscape of corporate finance, understanding the trends in Selling, General, and Administrative (SG&A) expenses is crucial. This analysis compares the SG&A expenses of Sarepta Therapeutics, Inc. and Walgreens Boots Alliance, Inc. from 2014 to 2023.
Sarepta Therapeutics, a leader in precision genetic medicine, has seen its SG&A expenses grow by nearly 900% over the past decade, reflecting its aggressive expansion and investment in research and development. From a modest $49 million in 2014, expenses surged to $482 million by 2023, highlighting the company's commitment to innovation.
In contrast, Walgreens Boots Alliance, a global pharmacy giant, maintained a relatively stable SG&A expense profile, with a slight increase of about 44% from $17.7 billion in 2014 to $25.5 billion in 2023. This stability underscores its focus on operational efficiency amidst a challenging retail environment.
Johnson & Johnson or Sarepta Therapeutics, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? AbbVie Inc. or Walgreens Boots Alliance, Inc.
Merck & Co., Inc. or Walgreens Boots Alliance, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Sarepta Therapeutics, Inc.
Breaking Down SG&A Expenses: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Who Optimizes SG&A Costs Better? BeiGene, Ltd. or Walgreens Boots Alliance, Inc.
Selling, General, and Administrative Costs: Catalent, Inc. vs Walgreens Boots Alliance, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Ascendis Pharma A/S
Sarepta Therapeutics, Inc. or Opthea Limited: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Axsome Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Walgreens Boots Alliance, Inc. and Exelixis, Inc.